Life Sciences
New life sciences study findings have been reported by researchers at Universitat Pompeu Fabra
Published in Obesity and Diabetes Week, March 8th, 2010
Scientists discuss in 'Central and peripheral consequences of the chronic blockade of CB1 cannabinoid receptor with rimonabant or taranabant' new findings in life sciences. "The endocannabinoid system plays a crucial role in the pathophysiology of obesity. However, the clinical use of cannabinoid antagonists has been recently stopped because of its central side-effects," scientists writing in the Journal of Neurochemistry report.
"The aim of this study was to compare the effects of a chronic treatment with the CB(1) cannabinoid antagonist rimonabant or the CB(1) inverse agonist taranabant in diet-induced obese female rats to clarify the biological consequences of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Wiley-Blackwell
Obesity and physical inactivity poses arthritis risk, especially for women - Abdominal Aortic Aneurysm
Data on abdominal aortic aneurysm detailed by researchers at Yale University, Medical Department - Angiotensins
Research from Catholic University, Medical Department in the area of angiotensins published - Attention Deficit Hyperactivity Disorder
Research on attention deficit hyperactivity disorder reported by M. Odent et al - Body Weight
Researchers from Niagara University publish new studies and findings in the area of body weight - Cardiovascular
Investigators at University of Chile, Medical Department release new data on cardiovascular - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
